|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||152.80 - 154.20|
|52 Week Range||105.00 - 164.15|
|Beta (5Y Monthly)||0.65|
|PE Ratio (TTM)||86.49|
|Forward Dividend & Yield||0.70 (0.47%)|
|Ex-Dividend Date||May 28, 2020|
|1y Target Est||N/A|
German defence supplier Hensoldt has filed for a Frankfurt stock market listing later this month, as the private equity-owned company seeks to raise funds for growth and to strengthen its balance sheet. The deal is expected to value the former Airbus unit, which buyout group KKR bought in 2016, at 2.5-3 billion euros ($3-3.5 billion), including debt, people close to the matter said.
Ladies and gentlemen and thank you for standing by, and welcome to the Dassault Systemes Q2 and H1 2020 Earnings Call. Thank you for joining us on our second quarter earnings conference call, with Bernard Charles, Vice Chairman and CEO; and Pascal Daloz, Chief Operating Officer and Chief Financial Officer. Dassault Systemes' results are prepared in accordance with IFRS.
The research, which was prepared by clinical trial technology company Medidata, shows that the number of new subjects entering trials increased 112% in June compared with the low point in April. Drugmakers around the world, including Eli Lilly & Co and Galapagos NV have announced plans to delay clinical trials for some drugs because of difficulties recruiting, treating and monitoring patients during the pandemic. In response, regulators, including the U.S. Food and Drug administration, have eased rules around collecting data remotely using digital tools to try to help drugmakers continue to research new treatments.